Navigation Links
Arcturus Therapeutics Announces Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH)
Date:12/6/2016

SAN DIEGO, Dec. 6, 2016 /PRNewswire/ -- Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), a leading RNA medicines company, announced today that it entered into collaboration with Takeda Pharmaceutical Company Limited, to develop RNA-based therapeutics for the treatment of NASH and other gastrointestinal (GI) related disorders, utilizing Arcturus' wholly-owned therapeutic delivery platform LUNAR™ and UNA Oligomer chemistry. The financial terms were not disclosed.

"Given Takeda's long-standing commitment to and expertise in GI disorders, we are confident we have found an ideal partner to accelerate and maximize the potential of our LUNAR and UNA technology platforms toward the development of novel RNA therapeutics for the treatment of NASH," said Dr. Pad Chivukula, CSO & COO of Arcturus Therapeutics, Inc. "This agreement underscores Arcturus' ability to rapidly discover, design and optimize RNA medicines in areas of unmet need." 

About Arcturus Therapeutics, Inc.   

Founded in 2013 and based in San Diego, Arcturus Therapeutics, Inc. is an RNA medicines company with enabling technologies — UNA Oligomer chemistry and LUNAR™ nanoparticle delivery. Arcturus' versatile RNA therapeutics platform can be applied toward all types of RNA medicines including small interfering RNA, messenger RNA, antisense RNA, microRNA and gene editing therapeutics. The company owns LUNAR™ nanoparticle delivery and unlocked nucleomonomer agent (UNA) technology including UNA Oligomers™, which are covered by its patent portfolio (77 patents and patent applications, issued in the U.S., Europe, Japan and other countries). Arcturus' proprietary UNA technology can be used to target any gene in the human genome, as well as viral genes, and other species for therapeutic purposes. The Company's commitment to the development of novel RNA therapeutics has led to collaborations and license agreements with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Ultragenyx Pharmaceutical, Inc. For more information, visit www.ArcturusRx.com.

Logo - http://photos.prnewswire.com/prnh/20130531/MM24393LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arcturus-therapeutics-announces-collaboration-with-takeda-pharmaceuticals-to-develop-rna-based-therapeutics-for-the-treatment-of-nonalcoholic-steatohepatitis-nash-300373830.html


'/>"/>
SOURCE Arcturus Therapeutics
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Arcturus Therapeutics Receives Intent to Grant Notice from the European Patent Office for their Unlocked Nucleomonomer Agent (UNA) Technology
2. Arcturus Therapeutics Announces the Appointment of Drew Weissman M.D., Ph.D. to the Scientific Advisory Board
3. Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications
4. Arcturus Therapeutics to Present at the Genetic Rx Boston Biotech Conference
5. Arcturus Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference
6. Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program
7. Arcturus Therapeutics Acquires Cutting-Edge UNA Patent Estate from Marina Biotech
8. Viking Therapeutics Receives Orphan Drug Designation for VK0214 from the U.S. Food and Drug Administration for the Treatment of X-Linked Adrenoleukodystrophy
9. Mission Therapeutics Appoints Colin Goddard as Chairman
10. Research Reports Initiation on Healthcare Stocks -- NuVasive, Smith & Nephew, Nxstage Medical, and Cesca Therapeutics
11. Research Reports Coverage on Biotech Stocks -- Celldex Therapeutics, Amicus Therapeutics, Navidea Biopharma, and Concordia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2018)... ... ... Shady Grove Fertility (SGF), a nationally recognized fertility and IVF ... countries around the world, announced today it’s expanding its program for Mandarin-speaking patients and ... see Mandarin and English-speaking patients in Rockville, MD and K-Street Washington, ...
(Date:12/13/2018)... ... December 13, 2018 , ... ... Annual Meeting April 1 to 4, 2019, at the Hyatt Regency in Chicago. ... speaking as well as 4,200-plus attendees. In attendance will be the top C-suite ...
(Date:12/10/2018)... ... December 10, 2018 , ... Parkstone Growth Partners ... of Parkview Dental Partners (“Parkview Dental”), a dentist-founded dental growth and management partnership. ... Dental, a group dental practice comprised of 16 dentists and hygienists across eight ...
Breaking Medicine Technology:
(Date:12/13/2018)... ... December 13, 2018 , ... Ross A. Clevens, MD, ... Hall of Fame, an honor recognizing the highest-rated and most active doctors on ... medical aesthetic providers. Dr. Clevens has been named a “Distinguished Inductee,” a distinction reserved ...
(Date:12/13/2018)... (PRWEB) , ... December 13, 2018 , ... ... designed to appear more modern and approachable in their community. Delia Associates created ... to provide treatment for those dealing with substance abuse in the greater Hunterdon ...
(Date:12/13/2018)... , ... December 13, 2018 , ... ... West Penn Hospital, and Westfield Memorial Hospital, all part of Allegheny Health Network ... Healthcare Information Management Executives (CHIME). , Most Wired® is the industry-leading survey on ...
(Date:12/10/2018)... , ... December 10, 2018 , ... In the aftermath ... situation has more recently been reinforced by the Me Too movement. To redress the ... set their inner Man free and become the Men they were always meant to ...
(Date:12/10/2018)... Fla. (PRWEB) , ... December 10, 2018 , ... ... Hospital Palm Harbor Emergency Room and Florida Hospital Wesley Chapel recently received the ... the category of patient experience. The award for both emergency and inpatient services ...
Breaking Medicine News(10 mins):